Edward Lewiecki, MD
Internal Medicine · Albuquerque, NMNPI 1861441735
Payments from drug & device makers
Across 1,008 payments — averaging $1511.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ultragenyx Pharmaceutical Inc.$635K
- Teva Pharmaceuticals USA, Inc.$214K
- Radius Health, Inc.$213K
- Amgen$213K
- Ascendis Pharma Endocrinology Inc$97K
- Kyowa Kirin, Inc.$93K
- plus $60K from 25 others
Across 9 payments — averaging $436.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Radius Health, Inc.$3K
- Amgen$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 154 | $634,691 |
| Teva Pharmaceuticals USA, Inc. | 19 | $213,541 |
| Radius Health, Inc. | 252 | $212,797 |
| Amgen | 210 | $212,717 |
| Ascendis Pharma Endocrinology Inc | 83 | $96,670 |
| Kyowa Kirin, Inc. | 139 | $92,679 |
| AstraZeneca(2 entities) | 86 | $32,821 |
| Sanofi | 1 | $10,600 |
| UCB SA | 3 | $4,880 |
| Samsung Bioepis Co., Ltd. | 1 | $4,250 |
| Novo Nordisk Health Care AG | 2 | $3,500 |
| Celltrion, Inc. | 1 | $1,500 |
| Bayer | 3 | $856 |
| Agios Pharmaceuticals, Inc. | 1 | $416 |
| Organon | 1 | $228 |
| Pfizer | 13 | $189 |
| Novo Nordisk | 13 | $176 |
| Shire North American Group Inc | 1 | $105 |
| Corcept Therapeutics | 7 | $96 |
| Pharmacosmos Therapeutics Inc. | 1 | $93 |
| Ipsen Biopharmaceuticals, Inc | 3 | $68 |
| Boehringer Ingelheim | 2 | $53 |
| Lilly USA, LLC | 2 | $49 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $39 |
| Johnson & Johnson | 2 | $37 |
| AbbVie | 1 | $23 |
| Astellas Pharma US Inc | 1 | $19 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| GSK | 1 | $14 |
| Merck | 1 | $13 |
How this compares
$1,523,151 in reported general payments places this provider in the 95th percentile of 578 internal medicine providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Albuquerque
- Michelle ValentineAlbuquerque$12.7M
- Lance RudolphAlbuquerque$980K
- Michelle IandiorioAlbuquerque$349K
- Nour Ass'adAlbuquerque$332K
- Joao TeixeiraAlbuquerque$259K
- Dulcinea QuintanaAlbuquerque$154K
- Gulshan ParasherAlbuquerque$145K
- James AdairAlbuquerque$108K
- Allen AdolpheAlbuquerque$102K
- Ian RabinowitzAlbuquerque$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.